This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Temporal Trends and Autopsy Findings of SUDEP Based on Medicolegal Investigations in the United States,” Cihan et al. reviewed medical examiner reports in 3 cities in the United States and found that although there was no correlation between sudden unexplained death in epilepsy (SUDEP) and diurnal patterns or time of year, there was a reduction in the incidence of SUDEP between 2009 and 2016. There was also no difference in autopsy findings between SUDEP- and non–SUDEP-related deaths associated with epilepsy. Bleasel was encouraged by these findings, which he attributed to increased awareness of SUDEP, access to affordable medical care, and prescribing antiseizure medications. However, he emphasized the importance of continued patient and family education about the risk of SUDEP, medication compliance, and treatment of comorbidities. He also noted that other studies have shown respiratory center neuronal cellular abnormalities in patients with SUDEP. Friedman et al. agreed that this positive trend is encouraging, but that it does not obviate the need to 1) counsel patients and families about SUDEP as part of general epilepsy care or 2) continue to pursue research to explain this reduction and minimize the risk of SUDEP as much as possible.
In “Temporal Trends and Autopsy Findings of SUDEP Based on Medicolegal Investigations in the United States,” Cihan et al. reviewed medical examiner reports in 3 cities in the United States and found that although there was no correlation between sudden unexplained death in epilepsy (SUDEP) and diurnal patterns or time of year, there was a reduction in the incidence of SUDEP between 2009 and 2016. There was also no difference in autopsy findings between SUDEP- and non–SUDEP-related deaths associated with epilepsy. Bleasel was encouraged by these findings, which he attributed to increased awareness of SUDEP, access to affordable medical care, and prescribing antiseizure medications. However, he emphasized the importance of continued patient and family education about the risk of SUDEP, medication compliance, and treatment of comorbidities. He also noted that other studies have shown respiratory center neuronal cellular abnormalities in patients with SUDEP. Friedman et al. agreed that this positive trend is encouraging, but that it does not obviate the need to 1) counsel patients and families about SUDEP as part of general epilepsy care or 2) continue to pursue research to explain this reduction and minimize the risk of SUDEP as much as possible.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2021 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
